Cipla appoints CEO for One India Business; grants stock options and ESARs

CIPLA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-2.2%1-day move

₹1380.60

prior close

₹1370.90

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.1+0.1+0.1+0.2-2.2-1.6-2.0+2.6+3.9+4.2+3.5+3.6——

Up moveDown movePending

AI summary

Cipla's board approved the appointment of Mr Shivam Puri as CEO – One India Business and Senior Management Personnel, effective July 1, 2026. Puri, currently MD & CEO of Cipla Health (wholly owned subsidiary), brings 23+ years of FMCG and healthcare experience from HUL, ITC, and Jubilant FoodWorks. Additionally, the board granted 11,360 stock options under ESOS 2013-A (2-year vesting, INR 2 exercise price) and 51,394 ESARs under ESAR 2021 (3-year graded vesting, INR 2 exercise price).

Likely market impact

Leadership continuity from Cipla Health to parent business; ESOP/ESAR grants at nominal INR 2 exercise price signal employee incentives with marginal dilution.